Enfermedades Sistémicas de Base Autoinmune

Diaz-Gallo, LM; Simeon, CP; Broen, JC; Ortego-Centeno, N; Beretta, L; Vonk, MC; Carreira, PE; Vargas, S; Roman-Ivorra, JA; Gonzalez-Gay, MA; Tolosa, C; Lopez-Longo, FJ; Espinosa, G; Vicente, EF; Hesselstrand, R; Riemekasten, G; Witte, T; Distler, JHW; Voskuyl, AE; Schuerwegh, AJ; Shiels, PG; Nordin, A; Padyukov, L; Hoffmann-Vold, AM; Scorza, R; Lunardi, C; Airo, P; van Laar, JM; Hunzelmann, N; Gathof, BS; Kreuter, A; Herrick, A; Worthington, J; Denton, CP; Zhou, XD; Arnett, FC; Fonseca, C; Koeleman, BPC; Assasi, S; Radstake, TRDJ; Mayes, MD; Martin, J.

Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(7): 1233-1238 Nº de citas: 26 [doi:10.1136/annrheumdis-2012-202357]

de la Torre, I; Valor, L; Nieto, JC; Hernandez, D; Martinez, L; Gonzalez, CM; Monteagudo, I; Longo, JL; Montoro, M; Carreno, L.

Anti-TNF treatments in rheumatoid arthritis: economic impact of dosage modification

Expert Review of Pharmacoeconomics & Outcomes Research. 2013; 13(3): 407-414 Nº de citas: 21 [doi:10.1586/ERP.13.24]

Colebatch, AN; Edwards, CJ; Ostergaard, M; van der Heijde, D; Balint, PV; D'Agostino, MA; Forslind, K; Grassi, W; Haavardsholm, EA; Haugeberg, G; Jurik, AG; Landewe, RBM; Naredo, E; O'Connor, PJ; Ostendorf, B; Potocki, K; Schmidt, WA; Smolen, JS; Sokolovic, S; Watt, I; Conaghan, PG.

EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis

ANNALS OF THE RHEUMATIC DISEASES. 2013; 72(6): 804-814 Nº de citas: 562 [doi:10.1136/annrheumdis-2012-203158]

Fernandez-Bello, I; Lopez-Longo, FJ; Arias-Salgado, EG; Jimenez-Yuste, V; Butta, NV.

Behcet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity

Orphanet Journal of Rare Diseases. 2013; 8: Nº de citas: 21 [doi:10.1186/1750-1172-8-81]

Iagnocco, A; Naredo, E; Bijlsma, JWJ.

Becoming a musculoskeletal ultrasonographer

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2013; 27(2): 271-281 Nº de citas: 11 [doi:10.1016/j.berh.2013.02.004]

Naredo, E; Valor, L; De la Torre, I; Martinez-Barrio, J; Hinojosa, M; Aramburu, F; Ovalles-Bonilla, JG; Hernandez, D; Montoro, M; Gonzalez, CM; Lopez-Longo, J; Monteagudo, I; Carreno, L.

Ultrasound Joint Inflammation in Rheumatoid Arthritis in Clinical Remission: How Many and Which Joints Should Be Assessed?

ARTHRITIS CARE & RESEARCH. 2013; 65(4): 512-517 Nº de citas: 72 [doi:10.1002/acr.21869]

Naredo, E; Acebes, C; Brito, E; de Agustin, JJ; de Miguel, E; Mayordomo, L; Moller, I; Moragues, C; Rejon, E; Rodriguez, A; Uson, J; Garrido, J; Martinez-Hernandez, D.

Three-dimensional Volumetric Ultrasound: A Valid Method for Blinded Assessment of Response to Therapy in Rheumatoid Arthritis

JOURNAL OF RHEUMATOLOGY. 2013; 40(3): 253-260 Nº de citas: 12 [doi:10.3899/jrheum.121103]

Naredo, E; Moller, I; Corrales, A; Bong, DA; Cobo-Ibanez, T; Corominas, H; Garcia-Vivar, ML; Macarron, P; Navio, T; Richi, P; Iagnocco, A; Garrido, J; Martinez-Hernandez, D.

Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs

RHEUMATOLOGY. 2013; 52(2): 376-381 Nº de citas: 13 [doi:10.1093/rheumatology/kes260]

Ortea, I; Roschitzki, B; Ovalles, JG; Longo, JL; de la Torre, I; Gonzalez, I; Gomez-Reino, JJ; Gonzalez, A.

Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis

Journal of Proteomics. 2012; 77: 372-382 Nº de citas: 45 [doi:10.1016/j.jprot.2012.09.011]

Aristimuno, C; Teijeiro, R; Valor, L; Alonso, B; Tejera-Alhambra, M; de Andres, C; Minarro, DO; Lopez-Lazareno, N; Faure, F; Sanchez-Ramon, S.

Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis

CLINICAL AND EXPERIMENTAL MEDICINE. 2012; 12(4): 247-255 Nº de citas: 37 [doi:10.1007/s10238-011-0172-3]

Iagnocco, A; Naredo, E.

Osteoarthritis: research update and clinical applications

RHEUMATOLOGY. 2012; 51: 2-5 Nº de citas: 23 [doi:10.1093/rheumatology/kes328]

Cenit, MC; Simeon, CP; Vonk, MC; Callejas-Rubio, JL; Espinosa, G; Carreira, P; Blanco, FJ; Narvaez, J; Tolosa, C; Roman-Ivorra, JA; Gomez-Garcia, I; Garcia-Hernandez, FJ; Gallego, M; Garcia-Portales, R; Egurbide, MV; Fonollosa, V; de la Pena, PG; Lopez-Longo, FJ; Gonzalez-Gay, MA; Hesselstrand, R; Riemekasten, G; Witte, T; Voskuyl, AE; Schuerwegh, AJ; Madhok, R; Fonseca, C; Denton, C; Nordin, A; Palm, O; van Laar, JM; Hunzelmann, N; Distler, JHW; Kreuter, A; Herrick, A; Worthington, J; Koeleman, BP; Radstake, TRDJ; Martin, J.

Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis

JOURNAL OF RHEUMATOLOGY. 2012; 39(12): 2294-2302 Nº de citas: 32 [doi:10.3899/jrheum.120506]

Valor, L; Sarmiento, E; Navarro, J; Gallego, A; Fernandez-Yanez, J; Fernandez-Cruz, E; Carbone, J.

Evaluation of Lymphoproliferative Responses by Carboxy Fluorescein Succinimidyl Ester Assay in Heart Recipients With Infections

TRANSPLANTATION PROCEEDINGS. 2012; 44(9): 2649-2652 Nº de citas: 4 [doi:10.1016/j.transproceed.2012.09.054]

Rivera, J; Rejas-Gutierrez, J; Vallejo, MA; Esteve-Vives, J; De Salas-Cansado, M.

Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(6): 31-38 Nº de citas: 15

Wakefield, RJ; D'Agostino, MA; Naredo, E; Buch, MH; Iagnocco, A; Terslev, L; Ostergaard, M; Backhaus, M; Grassi, W; Dougados, M; Burmester, GR; Saleem, B; de Miguel, E; Estrach, C; Ikeda, K; Gutierrez, M; Thompson, R; Balint, P; Emery, P.

After treat-to-target: can a targeted ultrasound initiative improve RA; outcomes?

POSTGRADUATE MEDICAL JOURNAL. 2012; 88(1042): 482-486 Nº de citas: 22 [doi:10.1136/postgradmedj-2011-201048rep]

Prior, N; Remor, E; Gomez-Traseira, C; Lopez-Serrano, C; Cabanas, R; Contreras, J; Campos, A; Cardona, V; Cimbollek, S; Gonzalez-Quevedo, T; Guilarte, M; de Rojas, DHF; Marcos, C; Rubio, M; Tejedor-Alonso, MA; Caballero, T.

Development of a disease-specific quality of life questionnaire for; adult patients with hereditary angioedema due to C1 inhibitor deficiency; (HAE-QoL): Spanish multi-centre research project

Health and Quality of Life Outcomes. 2012; 10: Nº de citas: 65 [doi:10.1186/1477-7525-10-82]

de la Torre, I; Leandro, MJ; Edwards, JCW; Cambridge, G.

Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012; 30(4): 554-560 Nº de citas: 14

Wakefield, RJ; D'Agostino, MA; Naredo, E; Buch, MH; Iagnocco, A; Terslev, L; Ostergaard, M; Backhaus, M; Grassi, W; Dougados, M; Burmester, GR; Saleem, B; de Miguel, E; Estrach, C; Ikeda, K; Gutierrez, M; Thompson, R; Balint, P; Emery, P.

After treat-to-target: can a targeted ultrasound initiative improve RA; outcomes?

ANNALS OF THE RHEUMATIC DISEASES. 2012; 71(6): 799-803 Nº de citas: 94 [doi:10.1136/annrheumdis-2011-201048]